bosentan Tablets 125 mg, 62.5 mg

Dossier type
Dossier status
Ready to file
Country of origin
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days


Bosentan is used to treat high blood pressure in a condition called pulmonary arterial hypertension, which effects the lungs. PAH is a condition that is caused by increased levels of an endothelin-1 in the body. It reduces the number of open wounds, especially on fingertips and knuckles. Bosentan is a dual endothelin receptor antagonist, in that it selectively inhibits the production of the substance Endothelin-1. The goal of Bosentan therapy is to improve ability to exercise and slow the progression of the disease. Bosentan has been shown effectiveness mostly in patients with symptoms that were rated as WHO Functional Class II-III.
In the USA, the European Union and other countries, the license of owned by Actelion Pharmaceuticals and sold under the trade name Tracleer.
Bosentan was approved for treatment for PAH in the US in 2001and in Europe in 2002.

Forms and Dosage

Bosentan is sold in film-coated tablets in strengths of 62.5 mg or 125 mg. It is also sold as dispersible tablets for oral suspension of 32 mg. Bosentan is administered as a single dose of 2000 mg/day for 2 months.
Bosentan harms fetuses so pregnant women are not prescribed this medicine, moreover, women taking Bosentan should not get pregnant. In the US, only doctors who follow an FDA-mandated risk evaluation and mitigation strategy (REMS) with respect to risks to fetuses and its risks of causing liver damage are allowed to prescribe it.

The wholesale cost of Bosentan

The average wholesale price is $49.50 per day for both 62.5 mg and 125 mg tablets and $2,970 per month in the USA. The same dose will cost 1510 pounds in the UK.
The price of Bosentan is significantly lower in the developing world, with the leading Indian brands costing only USD1 for 20 tablets of the same strength as sold in the USA or UK.
How does Bosentan work?
Bosentan is an antagonist of endothelin-1. When functioning normally, endothelin-1 causes the pulmonary blood vessels to constrict. Endothelin also causes abnormal growth of the muscle of the blood vessels in the lungs thus narrowing passages. This increases the pressure required to push the blood through the lungs to get oxygen. Conversely, Endothelin-1 has been associated with both vasodilation and vasoconstriction of vascular smooth muscle and tissue. Bosentan blocks the receptors, causing a total decrease in pulmonary vascular resistance.
Bosentan blocks off the effects of endothelin-1, which helps lower blood pressure in the lungs, slow the worsening of symptoms from the disease. Because it can reduce the stress on the lungs it also improves our ability to exercise and related research studies have verified this improvement.

Finding Bosentan Manufacturers and Suppliers

The process of finding trusted Bosentan manufacturers and Bosentan suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities.
The robust search engine makes it convenient to search for manufacturers and suppliers of Bosentan. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.